# FDA Inspection 1263915 - Tubilux Pharma Spa - June 14, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/tubilux-pharma-spa/31665e2a-33dc-471b-803b-4709debae59b/
Source feed: FDA_Inspections

> FDA Inspection 1263915 for Tubilux Pharma Spa on June 14, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263915
- Company Name: Tubilux Pharma Spa
- Inspection Date: 2024-06-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1115090 - 2019-12-10](https://www.globalkeysolutions.net/api/records/fda_inspections/tubilux-pharma-spa/33cc01b2-f57c-40aa-a2b6-4c3690df43d2/)
- [FDA Inspection 1047718 - 2018-04-06](https://www.globalkeysolutions.net/api/records/fda_inspections/tubilux-pharma-spa/6c2d27fc-317a-46ad-85a4-fd3fed10264b/)
- [FDA Inspection 998341 - 2016-12-09](https://www.globalkeysolutions.net/api/records/fda_inspections/tubilux-pharma-spa/8cacdb43-ba42-44ae-b6f2-de41dc44bb1d/)

Company: https://www.globalkeysolutions.net/companies/tubilux-pharma-spa/83daee41-4a1b-4274-bb2a-3922dcf3e9a4

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c